Two insiders at Oscar Health, Inc. (OSCR) have recently divested significant portions of their holdings. On June 29, 2026, Chief Executive Officer Mark T. Bertolini sold a total of 1,039,315 shares across two transactions, valued at approximately $29.95 million. The sales occurred at average prices of $28.60 and $29.11 per share.
These transactions by Mr. Bertolini represent a substantial reduction in his direct ownership. While insider selling can be attributed to various personal financial strategies, such as diversification or tax planning, the timing and scale of these sales may be of interest to market observers.
The filings come as Oscar Health continues to navigate the dynamic health insurance sector. Further analysis of insider activity and company performance will be crucial for understanding the ongoing implications of these transactions.